Medicines Co. Stock
Your prediction
Pros and Cons of Medicines Co. in the next few years
Pros
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Medicines Co. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Medicines Co. | - | - | - | - | - | - | - |
Opko Health Inc. | -1.990% | 3.324% | -3.794% | -8.830% | -14.933% | -64.295% | -42.276% |
Repligen Corp. | -4.640% | 0.421% | -2.758% | 8.648% | -7.428% | -4.287% | - |
Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. | - | 2.521% | 16.190% | -14.085% | 1.667% | 6.087% | -45.886% |
Comments
News
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
Johnson & Johnson (NYSE: JNJ) is one of the world's largest healthcare companies, with a diverse product portfolio that includes pharmaceuticals, medical devices and consumer health products
Johnson & Johnson is as Cheap as it’s Going to Get
Shares of Johnson & Johnson (NYSE: JNJ) are as cheap as they will get. The stock is down in premarket trading following the Q1 release, but there is a bottom in play and reality to face. Trading